May 11, 2022 / 05:00PM GMT
Jenene D. Thomas - Jenene Thomas Communications, LLC - CEO
Good afternoon, and thank you for joining us for the Virtual Investor CEO Spotlight event, featuring Outlook Therapeutics. My name is Jenene Thomas, I am CEO of JTC IR, and I will be the moderator for today's event. We are very excited to have Russ Trenary, President and CEO of Outlook Therapeutics for today's Spotlight event.
So before we get started, I want to remind our audience that Outlook Therapeutics is publicly listed on NASDAQ and trades under the ticker OTLK. During today's discussion, we will be making forward-looking statements, and I encourage everyone to view the company's latest SEC filings on their website at outlooktherapeutics.com for the latest information.
So welcome, Russ. We're so excited to have you join our Virtual Investor platform again.
C. Russell Trenary - Outlook Therapeutics, Inc. - President, CEO & Director
Thanks so much. Thanks for having us back, Jenene. It's a real pleasure.
Jenene D. Thomas - Jenene Thomas
Outlook Therapeutics Inc at JTC Team Investor CEO Spotlight Event (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot